Corbus Pharmaceuticals Holding (CRBP) — Capital Reinvestment Ratio

Latest as of September 2021: 0.01x

Corbus Pharmaceuticals Holding (CRBP) has a Capital Reinvestment Ratio of 0.01x as of September 2021, meaning it reinvests 0% of its operating cash flow ($856.95K) in capital expenditures ($7.70K). See Corbus Pharmaceuticals Holding net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$856.95K
USD

Capital Expenditures

$7.70K
USD

Data as of

Sep 2021
Most recent filing

Annual Capital Reinvestment Ratio for Corbus Pharmaceuticals Holding (None–None)

Year-by-year Capital Reinvestment Ratio for Corbus Pharmaceuticals Holding from None to None. For live market cap and broader valuation context, see CRBP company net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow